Berne T V, Yellin A E, Appleman M D, Gill M A, Chenella F C, Heseltine P N
Ann Surg. 1987 Feb;205(2):133-7. doi: 10.1097/00000658-198702000-00006.
A randomized, double-blinded, controlled clinical study of 84 patients with surgically treated gangrenous or perforated appendicitis was done to compare the efficacy of the combination of aztreonam, the first monobactam antibiotic, with gentamicin when either was combined with clindamycin. Fifty-six patients who were treated with aztreonam and clindamycin (A/C) and 28 patients who were treated with gentamicin and clindamycin (G/C) fulfilled criteria for evaluation. A matched historic control group of 56 G/C patients was also included for comparison. All measures of outcome, including days of fever, hospitalization, antibiotic therapy, and the incidence of antibiotic failures, were similar. It was concluded that aztreonam was as effective as gentamicin in this study and may offer some advantages with regard to toxicity and serum drug level monitoring.
对84例接受手术治疗的坏疽性或穿孔性阑尾炎患者进行了一项随机、双盲、对照临床研究,以比较第一种单环β-内酰胺类抗生素氨曲南与庆大霉素分别与克林霉素联合使用时的疗效。56例接受氨曲南和克林霉素(A/C)治疗的患者以及28例接受庆大霉素和克林霉素(G/C)治疗的患者符合评估标准。还纳入了一个由56例G/C患者组成的匹配历史对照组进行比较。所有结局指标,包括发热天数、住院时间、抗生素治疗情况以及抗生素治疗失败的发生率,均相似。研究得出结论,在本研究中氨曲南与庆大霉素疗效相当,且在毒性和血清药物水平监测方面可能具有一些优势。